Genes and cardiovascular health each contribute in an additive way to a person’s risk of dementia, researchers including Sudha Seshadri, MD, and Claudia Satizabal, PhD, of UT Health San Antonio reported July 20 in the journal Neurology.
Drug Target Review: Synapse-protecting protein could be a target for Alzheimer’s therapies
Researchers at UT Health San Antonio have discovered a new class of proteins that protect synapses from being destroyed. The discovery, published July 13 in the journal Nature Neuroscience, has implications for Alzheimer’s disease and schizophrenia.
Texas Standard: A San Antonio hospital is the world’s largest study site for a COVID-19 drug in high demand
Dr. Thomas Patterson, Infectious Diseases, discusses the international remdesivir clinical trial being conducted in partnership with University Health System. He says the first phase of the study determined that the drug significantly reduced recovery time for patients with COVID-19.
The Comfort News: ‘We Can Stop the Spread’ urges disciplined choices to protect our South Texas families
With emphasis placed on including our surrounding communities that span across the region’s service area, the “We Can Stop the Spread” message was shared with, and published by, The Comfort News.
Asian News International: Study factors in genes, cardiovascular health into dementia risk
Genes and cardiovascular health each contribute additionally to a person’s risk of dementia, according to new research, published in the journal Neurology.
The study was done by U.S. researchers including Sudha Seshadri, MD, and Claudia Satizabal, PhD. The study was conducted in 1,211 participants in the Framingham Heart Study and involved collaborators from Boston University.
KSAT 12: 5 charts explain COVID-19 surge in San Antonio
A surge in symptomatic patients can quickly overrun the health care system, UT Health San Antonio President Dr. William Henrich has previously warned during a KSAT interview on June 16.